Melinta Gets OK For Ch. 11 Equity Swap Plan With Creditor
Bankrupt antibiotic developer Melinta Therapeutics received court approval Thursday in Delaware for its proposed Chapter 11 debt-for-equity transaction that will see a secured creditor acquire the reorganized company in exchange for...To view the full article, register now.
Already a subscriber? Click here to view full article